Search

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To compare and analyze the clinical effects of the two different repairment on the residual root and crown of maxillary anterior teeth. Methods: 120 cases of patients with anterior teeth defect or crown fracture who needed surgery to repair the line core crown pile from October 2011 to December 2013 in our hospital were randomly divided into glass fiber pile group and cast metal pile group, each with 60 cases. Glass fiber pile group were given nuclear and porcelain crown treatment. Cast metal pile group were given chromium alloy cast post and core drilling with a porcelain crown treatment, restorative treatment efficacy and failures of two groups were compared. Results: Glass fiber pile group had 1 case due to the relocation lost to follow-up, follow-cast metal pile group had2 cases patients of treatment interruption due to metal sensitization, which were removed. In the rest 117 cases(179 tooth) of patients, the glass fiber pile group had 92 teeth, the success rate was 89.13 %, cast metal pile group had 87 teeth, and the success rate was 79.31%,significantly higher than the fiberglass cast metal pile group; glass fiber pile group root fracture, the incidence of post-core loose or fall off was significantly lower than that of cast metal pile group; while the incidence of nuclear pile off the pile group was significantly higher than that of cast metal pile group. The difference was statistically significant(P <0.05). Conclusion: Glass fiber post is beautiful,fatigue, easy to operate, results in fewer patient referral and there is no cell toxicity and allergic reactions or other complications, the repair is better than that of metal post. [ABSTRACT FROM AUTHOR]

Copyright of Progress in Modern Biomedicine is the property of Publishing House of Progress in Modern Biomedicine and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Objective: To study the clinical efficacy of Ranibizumab and Conbercept in the treatment of patients with age-related macular degeneration (AMD). Methods: A total of 60 patients (60 eyes) with AMD in our hospital from June 2015 to October 2016 were enrolled, the subjects were divided into control group and treatment group according to the random number table method. The control group was treated with Ranibizumab. and the treatment group were treated with Ranibizumab combined with Conbercept. The two groups were treated for 3 months. The clinical efficacy of the two groups were compared. The total improvement rate of the retinal leakage of the two groups after treatment were compared. And the best corrected visual acuity and macular thickness of the two groups before and after treatment were compared. Results: The increase rate of the vision of the treatment group was 80.00%, which was significantly higher than 55.00% of the control group, the difference was statistically [significant (X2=4.104, P=0.043). The total improvement rate of the retinal leakage of the treatment group was 92.50%, which was significantly higher than 70.00% of the control group, the difference was statistically significant (X2=5.294, P=0.021). There were no significandy differences of the best corrected visual acuity and macular thickness of the two groups before treatment (P>0.05). The best corrected visual acuity of the two groups after treatment were significandy higher than before treatment, the macular thickness of the two groups after treatment were significandy lower than before treatment, and the treatment group were better than the control group, the difference was statistically significant (P<0.05). Conclusion: Ranibizumab combined with Conbercept have good clinical efficacy in the treatment of patients with AMD.which can significandy improve eyesight and reduce the leakage of the retina, it is worthy of clinical application. [ABSTRACT FROM AUTHOR]